Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
0.962
-0.038 (-3.81%)
At close: Jan 17, 2025, 4:00 PM
0.933
-0.029 (-3.00%)
After-hours: Jan 17, 2025, 5:49 PM EST
Gossamer Bio Employees
Gossamer Bio had 135 employees as of December 31, 2023. The number of employees decreased by 43 or -24.16% compared to the previous year.
Employees
135
Change (1Y)
-43
Growth (1Y)
-24.16%
Revenue / Employee
$780,163
Profits / Employee
-$530,719
Market Cap
217.97M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
GOSS News
- 13 days ago - Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 2 months ago - Gossamer Bio Announces Third Quarter 2024 Financial Results and Provides Business Update - Business Wire
- 4 months ago - Gossamer Bio Has One More Shot On Goal And Is Not Likely To Miss - Seeking Alpha
- 5 months ago - Gossamer Bio Announces Data Presentations at the European Respiratory Society Congress 2024 - Business Wire
- 5 months ago - Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now - GlobeNewsWire
- 5 months ago - Gossamer Bio Announces Second Quarter 2024 Financial Results and Provides Business Update - Business Wire
- 7 months ago - Gossamer Bio's Clean Safety Profile Differentiates It From Merck, Analyst Says - Benzinga
- 8 months ago - Gossamer Bio to Provide Updated Seralutinib TORREY Open-Label Extension Data at the American Thoracic Society 2024 International Conference - Business Wire